$100M Program Aims to Improve Diversity in Clinical Trials & What No One Tells You After a Diagnosis

Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses a new $100M program aimed to improve diversity in clinical trials.

Plus, Multiple Sclerosis News Today’s columnist, Jessie Ace, talks through the main mental health points that doctors don’t tell you after your diagnosis, such as going through the five stages of grief.

=====================================
Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.

=====================================

Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/

=====================================

To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/